Last reviewed · How we verify
Sertraline/Corn Oil
Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain.
Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain. Used for Major depressive disorder, Obsessive-compulsive disorder, Panic disorder.
At a glance
| Generic name | Sertraline/Corn Oil |
|---|---|
| Sponsor | Washington University School of Medicine |
| Drug class | SSRI |
| Target | Serotonin transporter |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
By blocking the reuptake of serotonin, sertraline allows more serotonin to be available in the synaptic cleft, which can help alleviate symptoms of depression and anxiety. Sertraline's mechanism of action is not directly related to corn oil, which is likely used as a vehicle or excipient in the formulation.
Approved indications
- Major depressive disorder
- Obsessive-compulsive disorder
- Panic disorder
- Post-traumatic stress disorder
- Social anxiety disorder
Common side effects
- Nausea
- Headache
- Dizziness
- Fatigue
- Insomnia
Key clinical trials
- Omega-3 for Depression and Other Cardiac Risk Factors - 2 (PHASE2)
- Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sertraline/Corn Oil CI brief — competitive landscape report
- Sertraline/Corn Oil updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI